sitagliptin/metformin reddy 50mg/1000mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a sitagliptin
sitagliptin/metformin reddy 50mg/850mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a sitagliptin
sitagliptin reddy 100mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 100mg - sitagliptin
sitagliptin reddy 25mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 25mg - sitagliptin
sitagliptin reddy 50mg potahovaná tableta
reddy holding gmbh, augsburg array - 41 monohydrÁt sitagliptin-hydrochloridu - potahovaná tableta - 50mg - sitagliptin
sugammadex reddy 100mg/ml injekční roztok
reddy holding gmbh, augsburg array - 17066 sodnÁ sŮl sugammadexu - injekční roztok - 100mg/ml - sugammadex
poulvac e. coli
zoetis belgium sa - Živý aroa gen odstranil escherichia coli, typ 078, kmen ec34195 - imunopreparát pro aves, Živé bakteriální vakcíny - chicken; turkeys - pro aktivní imunizaci brojlerů a budoucích vrstev / chovatelů za účelem snížení mortality a lézí (perikarditida, perihepatitis, airsacculitis) spojených s escherichia coli, sérotyp o78.
enteroporc coli
ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - imunologická vyšetření pro suidae - prasata - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.
enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - prasata - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.